These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 23527672

  • 1. Samarium-153-lexidronam therapy for metastatic bone pain.
    Ribera H.
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):80-1; discussion 81-2. PubMed ID: 23527672
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.
    Sartor O, Reid RH, Bushnell DL, Quick DP, Ell PJ.
    Cancer; 2007 Feb 01; 109(3):637-43. PubMed ID: 17167764
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of repeated samarium-153 lexidronam treatment in a patient with prostate cancer and metastatic bone pain.
    Menda Y, Bushnell DL, Williams RD, Miller S, Thomas MO.
    Clin Nucl Med; 2000 Sep 01; 25(9):698-700. PubMed ID: 10983757
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Incident pain and analgesic consumption decrease after samarium infusion: a pilot study.
    Ripamonti C, Fagnoni E, Campa T, Seregni E, Maccauro M, Bombardieri E.
    Support Care Cancer; 2007 Mar 01; 15(3):339-42. PubMed ID: 16967302
    [Abstract] [Full Text] [Related]

  • 6. Treatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combined.
    Lam MG, de Klerk JM, Zonnenberg BA.
    J Palliat Med; 2009 Jul 01; 12(7):649-51. PubMed ID: 19594354
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Liepe K, Kotzerke J.
    Nucl Med Commun; 2007 Aug 01; 28(8):623-30. PubMed ID: 17625384
    [Abstract] [Full Text] [Related]

  • 9. Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer.
    Sartor O, Reid RH, Hoskin PJ, Quick DP, Ell PJ, Coleman RE, Kotler JA, Freeman LM, Olivier P, Quadramet 424Sm10/11 Study Group.
    Urology; 2004 May 01; 63(5):940-5. PubMed ID: 15134985
    [Abstract] [Full Text] [Related]

  • 10. [Cost-effectiveness of samarium-153-EDTMP for the treatment of pain due to multiple bone metastases in hormone-refractory prostate cancer versus conventional pain therapy, in Portugal].
    Macedo A, Araújo A, Melo FC, Nunes G, Cantinho G, Amorin I.
    Acta Med Port; 2006 May 01; 19(5):421-6. PubMed ID: 17376329
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.
    Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahmann FR, Orihuela E, Reid RH, Lerski RA, Collier BD, McKillop JH, Purnell GL, Pecking AP, Thomas FD, Harrison KA.
    J Clin Oncol; 1998 Apr 01; 16(4):1574-81. PubMed ID: 9552068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Optimal treatment of painful bone metastases with Samarium EDTMP in a haemodialysis patient: effectiveness and safety of internal radiotherapy.
    Skalli S, Desruet MD, Bourre JC, Caravel JP, Vuillez JP.
    Nephrol Dial Transplant; 2009 Aug 01; 24(8):2598-600. PubMed ID: 19369693
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of samarium-153-ethylenediaminetetramethylene phosphonic acid with pamidronate disodium in the treatment of patients with painful metastatic bone cancer.
    Wang RF, Zhang CL, Zhu SL, Zhu M.
    Med Princ Pract; 2003 Aug 01; 12(2):97-101. PubMed ID: 12634464
    [Abstract] [Full Text] [Related]

  • 18. Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
    Anderson P, Nuñez R.
    Expert Rev Anticancer Ther; 2007 Nov 01; 7(11):1517-27. PubMed ID: 18020921
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.